Axcella Health Inc. (AXLA) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Societe des Produits Nestle S.A. con 11,105,438 acciones. Otros tenedores destacados incluyen NESTLE SA y Nestle Health Science US Holdings, Inc..
AXLA Participación de Insiders
Principal Titular
Societe des Produits Nestle S.A.
11,105,438 acciones
Compras (12 meses)
0
$0.00 valor
Ventas (12 meses)
0
$0.00 valor
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Societe Des Produits Nestle S.a. |
10 Percent Owner |
11,105,438 |
2022-10-17 |
|
| 2 |
Nestle Sa |
Director |
11,105,438 |
2022-10-17 |
|
| 3 |
Nestle Health Science Us Holdings, Inc. |
10 Percent Owner |
4,305,541 |
2020-05-21 |
|
| 4 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
3,048,780 |
2022-10-17 |
|
| 5 |
Flagship Pioneering Inc. |
Director |
3,048,780 |
2022-10-17 |
|
| 6 |
Afeyan Noubar |
Director |
3,048,780 |
2022-10-17 |
|
| 7 |
Hinshaw William |
President & CEO |
275,000 |
2023-02-24 |
|
| 8 |
Epstein David R |
Director |
209,756 |
2022-06-03 |
|
| 9 |
Chakravarthy Manu |
SVP & Chief Medical Officer |
102,000 |
2021-02-11 |
|
| 10 |
Dean Virginia R |
SVP, Chief People Officer |
71,400 |
2022-02-10 |
|
| 11 |
Fehlner Paul |
SVP & Chief Legal Officer |
70,000 |
2023-02-24 |
|
| 12 |
Schecter Alison D. |
President - Research & Dev. |
56,000 |
2022-02-10 |
|
| 13 |
Tramontin Tony |
SVP & Chief Scientific Officer |
45,000 |
2019-12-20 |
|
| 14 |
Mitchener Stephen |
SVP & Chief Business Officer |
43,000 |
2019-12-20 |
|
| 15 |
Rosiello Robert L. |
Director |
40,000 |
2022-11-18 |
|
| 16 |
Sekhri Paul J |
Director |
40,000 |
2022-05-25 |
|
| 17 |
Rosenblatt Michael |
Director |
40,000 |
2022-05-23 |
|
| 18 |
Hendrix Martin |
Director |
40,000 |
2022-05-23 |
|
| 19 |
Nissen Torben Straight |
Director |
40,000 |
2022-11-18 |
|
| 20 |
Crane Robert |
Chief Financial Officer |
39,267 |
2022-03-18 |
|
No hay datos de propiedad disponibles para AXLA.
